These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Endocrine disorders in toxic goiter in the postoperative period]. Krivitskiĭ DI Vestn Khir Im I I Grek; 1981 Jan; 126(1):57-9. PubMed ID: 6164150 [TBL] [Abstract][Full Text] [Related]
44. [Electro-impulse therapy in combined treatment of patients with thyrotoxic goiter complicated by cardiac fibrillation]. Parkhisenko IuA; Bogdanov AN; Udovichenbko SV Khirurgiia (Mosk); 2001; (9):12-4. PubMed ID: 11589018 [TBL] [Abstract][Full Text] [Related]
45. [Complications following surgical treatment of thyrotoxic goiter]. Gilevich IuS; Us TL; Khasanov AZ; Kipkeev DI Khirurgiia (Mosk); 1972 Sep; 48(9):6-10. PubMed ID: 4679163 [No Abstract] [Full Text] [Related]
49. [Basal metabolism in thyrotoxic goiter and in the remote period after its surgical treatment]. Kal'chenko II; Khokholia VP Sov Med; 1971 Oct; 34(10):116-20. PubMed ID: 5171751 [No Abstract] [Full Text] [Related]
50. [Complications of thyroid surgery. Apropos of 300 cases]. Najeh D; Kooli H; Ben Salah M; Oueslati Z; Marreckchi M; Hajri H; Ferjaoui M Tunis Med; 1998 Mar; 76(3):28-30. PubMed ID: 9844529 [No Abstract] [Full Text] [Related]
51. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma. Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014 [TBL] [Abstract][Full Text] [Related]
52. [Total cortisol concentration in the surgical treatment of hyperthyroid goiter]. Puchalski Z Pol Przegl Chir; 1976 Dec; 48(12):1521-6. PubMed ID: 1036775 [No Abstract] [Full Text] [Related]
53. [Use of gelvisol in the preparation of patients with toxic goiter for surgery]. Zarivchatskiĭ MF Vestn Khir Im I I Grek; 1983 Dec; 131(12):12-4. PubMed ID: 6689454 [TBL] [Abstract][Full Text] [Related]
54. [Long-term results of surgical treatment in 36 patients with Basedow's disease]. Eccher C; Urschitz T; Zulian S; Girelli ME; Benintendi V; Betterle C Minerva Med; 1980 Jun; 71(23):1671-6. PubMed ID: 6892952 [No Abstract] [Full Text] [Related]
55. [Radiotherapy of postoperative recurrences of toxic goiter]. Gorbadeĭ NK; Kucherova ID; Reznikova IV Vrach Delo; 1971 Apr; 7():80-3. PubMed ID: 5172132 [No Abstract] [Full Text] [Related]
56. [Effects of preoperative preparation and surgical treatment of thyrotoxic goiter on the hepatic function in aged patients]. Mrozek TK Vestn Khir Im I I Grek; 1966 Jan; 96(1):27-31. PubMed ID: 6013196 [No Abstract] [Full Text] [Related]
57. Is euthyroidism the goal of surgical treatment of diffuse toxic goitre? Torre G; Borgonovo G; Arezzo A; Costantini M; Varaldo E; Ansaldo GL; Mattioli FP Eur J Surg; 1998 Jul; 164(7):495-500. PubMed ID: 9696970 [TBL] [Abstract][Full Text] [Related]
58. [Surgical treatment of Graves-Basedow disease. Descriptive study and review of the literature]. Pino Rivero V; Guerra Camacho M; Keituqwa Yáñez T; Pardo Romero G; Blasco Huelva A An Otorrinolaringol Ibero Am; 2003; 30(6):555-61. PubMed ID: 14971135 [TBL] [Abstract][Full Text] [Related]
59. [Effect of complex treatment on the blood gas state in patients with toxic goiter]. Savchenko AA Vrach Delo; 1967; 7():71-4. PubMed ID: 5633322 [No Abstract] [Full Text] [Related]
60. [Special surgical treatment of patients with nodular tumors of the thyroid gland against the background of diffuse toxic goiter]. Romanchishen AF; Iakovlev PN Vestn Khir Im I I Grek; 2005; 164(1):21-4. PubMed ID: 15957803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]